NR4A1 and cervical adenocarcinoma: Thus, if p16 and hormone receptor immunohistochemistry is used in an attempt to distinguish between endometrial and cervical tumor origin, a pattern of diffuse p16 expression and negative or focal hormone receptor expression could result in the misdiagnosis of a primary cervical adenocarcinoma, with resultant inappropriate management.